Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram and Copper Gluconate in Metastatic Pancreatic Cancer
NCT03714555Phase 2Terminated
- Sponsor
- HonorHealth Research Institute
- Start
- Oct 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of disulfiram and copper gluconate (3 arms), sponsored by HonorHealth Research Institute. Primary endpoint: CA19-9 Plasma Level up to 100 months. Started Oct 2019; status: terminated.
02
Drugs
disulfiramcopper gluconate
Beyond the preview
Go deeper on NCT03714555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03714555.